Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Recurrent Skin Squamous Cell Carcinoma × Hyaluronoglucosaminidase × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 3 Carcinoma, Non-Small-Cell Lung 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma, Mantle-Cell 1 Lung Neoplasms 1 Locally Recurrent Skin Squamous Cell Carcinoma 1 Endometrial Neoplasms 1 Classic Follicular Lymphoma 1

Interventions

amivantamab 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Hyaluronoglucosaminidase 1 Cetuximab 1 (225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07042295 2026-03-18

Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System

National Cancer Institute (NCI)

Phase 2 Recruiting

Locally Recurrent Skin Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡